Notable Analyst Rating Changes 9/8: (LLY) (ENB) (JCI) Upgraded; (NKE) (ABBV) (AAPL) Downgraded
Tweet Send to a Friend
UPGRADES
JPMorgan upgraded Eli Lilly (NYSE: LLY) from Neutral to Overweight with a price target of $95.Goldman Sachs upgraded Enbridge ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan upgraded Eli Lilly (NYSE: LLY) from Neutral to Overweight with a price target of $95.Goldman Sachs upgraded Enbridge ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
